Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jul 7;12(7):1035-1037.
doi: 10.2215/CJN.05170517. Epub 2017 Jun 19.

The Potential of Pharmacogenomics to Advance Kidney Disease Treatment

Kelly A Birdwell  1 , Cecilia P Chung  2
Affiliations
Editorial

The Potential of Pharmacogenomics to Advance Kidney Disease Treatment

Kelly A Birdwell et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: human genetics; mineral metabolism.

PubMed Disclaimer

Comment on

References

    1. Roden DM, Altman RB, Benowitz NL, Flockhart DA, Giacomini KM, Johnson JA, Krauss RM, McLeod HL, Ratain MJ, Relling MV, Ring HZ, Shuldiner AR, Weinshilboum RM, Weiss ST; Pharmacogenetics Research Network: Pharmacogenomics: Challenges and opportunities. Ann Intern Med 145: 749–757, 2006 - PMC - PubMed
    1. Roses AD: Pharmacogenetics and drug development: The path to safer and more effective drugs. Nat Rev Genet 5: 645–656, 2004 - PubMed
    1. Collins FS, Varmus H: A new initiative on precision medicine. N Engl J Med 372: 793–795, 2015 - PMC - PubMed
    1. Amin AM, Sheau Chin L, Azri Mohamed Noor D, Sk Abdul Kader MA, Kah Hay Y, Ibrahim B: The personalization of clopidogrel antiplatelet therapy: The role of integrative pharmacogenetics and pharmacometabolomics. Cardiol Res Practice 2017: 8062796, 2017 - PMC - PubMed
    1. Mega JL, Close SL, Wiviott SD, Shen L, Walker JR, Simon T, Antman EM, Braunwald E, Sabatine MS: Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: A pharmacogenetic analysis. Lancet 376: 1312–1319, 2010 - PMC - PubMed